Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Report 2018

February 2018 | 119 pages | ID: A89F6730FBAQEN
QYResearch

Abstracts

In this report, the Asia-Pacific Alpha- Antitrypsin Deficiency Treatment market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Alpha- Antitrypsin Deficiency Treatment for these regions, from 2013 to 2025 (forecast), including

• China
• Japan
• South Korea
• Taiwan
• India
• Southeast Asia
• Australia

Asia-Pacific Alpha- Antitrypsin Deficiency Treatment market competition by top manufacturers/players, with Alpha- Antitrypsin Deficiency Treatment sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Adverum Biotechnologies, Inc.
• Alnylam Pharmaceuticals, Inc.
• Applied Genetic Technologies Corporation
• Arrowhead Pharmaceuticals, Inc.
• Carolus Therapeutics, Inc.
• Cevec Pharmaceuticals GmbH
• Dicerna Pharmaceuticals, Inc.
• Digna Biotech, S.L.
• Editas Medicine, Inc.
• Grifols, S.A.
• Inhibrx
• Intellia Therapeutics, Inc.
• International Stem Cell Corporation
• Ionis Pharmaceuticals, Inc.
• Kamada Ltd.
• Polyphor Ltd.
• ProMetic Life Sciences Inc.
• rEVO Biologics, Inc.
• Sangamo BioSciences, Inc.

On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into

• CT-2009
• POL-6014
• ARO-AAT
• ALNAAT-02
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Clinic
• Hospital
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Report 2018

1 ALPHA- ANTITRYPSIN DEFICIENCY TREATMENT OVERVIEW

1.1 Product Overview and Scope of Alpha- Antitrypsin Deficiency Treatment
1.2 Classification of Alpha- Antitrypsin Deficiency Treatment by Product Category
  1.2.1 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Size (Sales) Comparison by Types (2013-2025)
  1.2.2 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 CT-2009
  1.2.4 POL-6014
  1.2.5 ARO-AAT
  1.2.6 ALNAAT-02
  1.2.7 Others
1.3 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market by Application/End Users
  1.3.1 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Sales (Volume) and Market Share Comparison by Applications (2013-2025)
  1.3.2 Clinic
  1.3.3 Hospital
  1.3.4 Others
1.4 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market by Region
  1.4.1 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 China Status and Prospect (2013-2025)
  1.4.3 Japan Status and Prospect (2013-2025)
  1.4.4 South Korea Status and Prospect (2013-2025)
  1.4.5 Taiwan Status and Prospect (2013-2025)
  1.4.6 India Status and Prospect (2013-2025)
  1.4.7 Southeast Asia Status and Prospect (2013-2025)
  1.4.8 Australia Status and Prospect (2013-2025)
1.5 Asia-Pacific Market Size (Value and Volume) of Alpha- Antitrypsin Deficiency Treatment (2013-2025)
  1.5.1 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Sales and Growth Rate (2013-2025)
  1.5.2 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Revenue and Growth Rate (2013-2025)

2 ASIA-PACIFIC ALPHA- ANTITRYPSIN DEFICIENCY TREATMENT COMPETITION BY PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Competition by Players/Suppliers
  2.1.1 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Sales Volume and Market Share of Key Players/Suppliers (2013-2018)
  2.1.2 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Revenue and Share by Players/Suppliers (2013-2018)
2.2 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment (Volume and Value) by Type
  2.2.1 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Sales and Market Share by Type (2013-2018)
  2.2.2 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Revenue and Market Share by Type (2013-2018)
2.3 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment (Volume) by Application
2.4 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment (Volume and Value) by Region
  2.4.1 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Sales and Market Share by Region (2013-2018)
  2.4.2 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Revenue and Market Share by Region (2013-2018)

3 CHINA ALPHA- ANTITRYPSIN DEFICIENCY TREATMENT (VOLUME, VALUE AND SALES PRICE)

3.1 China Alpha- Antitrypsin Deficiency Treatment Sales and Value (2013-2018)
  3.1.1 China Alpha- Antitrypsin Deficiency Treatment Sales Volume and Growth Rate (2013-2018)
  3.1.2 China Alpha- Antitrypsin Deficiency Treatment Revenue and Growth Rate (2013-2018)
  3.1.3 China Alpha- Antitrypsin Deficiency Treatment Sales Price Trend (2013-2018)
3.2 China Alpha- Antitrypsin Deficiency Treatment Sales Volume and Market Share by Type
3.3 China Alpha- Antitrypsin Deficiency Treatment Sales Volume and Market Share by Application

4 JAPAN ALPHA- ANTITRYPSIN DEFICIENCY TREATMENT (VOLUME, VALUE AND SALES PRICE)

4.1 Japan Alpha- Antitrypsin Deficiency Treatment Sales and Value (2013-2018)
  4.1.1 Japan Alpha- Antitrypsin Deficiency Treatment Sales Volume and Growth Rate (2013-2018)
  4.1.2 Japan Alpha- Antitrypsin Deficiency Treatment Revenue and Growth Rate (2013-2018)
  4.1.3 Japan Alpha- Antitrypsin Deficiency Treatment Sales Price Trend (2013-2018)
4.2 Japan Alpha- Antitrypsin Deficiency Treatment Sales Volume and Market Share by Type
4.3 Japan Alpha- Antitrypsin Deficiency Treatment Sales Volume and Market Share by Application

5 SOUTH KOREA ALPHA- ANTITRYPSIN DEFICIENCY TREATMENT (VOLUME, VALUE AND SALES PRICE)

5.1 South Korea Alpha- Antitrypsin Deficiency Treatment Sales and Value (2013-2018)
  5.1.1 South Korea Alpha- Antitrypsin Deficiency Treatment Sales Volume and Growth Rate (2013-2018)
  5.1.2 South Korea Alpha- Antitrypsin Deficiency Treatment Revenue and Growth Rate (2013-2018)
  5.1.3 South Korea Alpha- Antitrypsin Deficiency Treatment Sales Price Trend (2013-2018)
5.2 South Korea Alpha- Antitrypsin Deficiency Treatment Sales Volume and Market Share by Type
5.3 South Korea Alpha- Antitrypsin Deficiency Treatment Sales Volume and Market Share by Application

6 TAIWAN ALPHA- ANTITRYPSIN DEFICIENCY TREATMENT (VOLUME, VALUE AND SALES PRICE)

6.1 Taiwan Alpha- Antitrypsin Deficiency Treatment Sales and Value (2013-2018)
  6.1.1 Taiwan Alpha- Antitrypsin Deficiency Treatment Sales Volume and Growth Rate (2013-2018)
  6.1.2 Taiwan Alpha- Antitrypsin Deficiency Treatment Revenue and Growth Rate (2013-2018)
  6.1.3 Taiwan Alpha- Antitrypsin Deficiency Treatment Sales Price Trend (2013-2018)
6.2 Taiwan Alpha- Antitrypsin Deficiency Treatment Sales Volume and Market Share by Type
6.3 Taiwan Alpha- Antitrypsin Deficiency Treatment Sales Volume and Market Share by Application

7 INDIA ALPHA- ANTITRYPSIN DEFICIENCY TREATMENT (VOLUME, VALUE AND SALES PRICE)

7.1 India Alpha- Antitrypsin Deficiency Treatment Sales and Value (2013-2018)
  7.1.1 India Alpha- Antitrypsin Deficiency Treatment Sales Volume and Growth Rate (2013-2018)
  7.1.2 India Alpha- Antitrypsin Deficiency Treatment Revenue and Growth Rate (2013-2018)
  7.1.3 India Alpha- Antitrypsin Deficiency Treatment Sales Price Trend (2013-2018)
7.2 India Alpha- Antitrypsin Deficiency Treatment Sales Volume and Market Share by Type
7.3 India Alpha- Antitrypsin Deficiency Treatment Sales Volume and Market Share by Application

8 SOUTHEAST ASIA ALPHA- ANTITRYPSIN DEFICIENCY TREATMENT (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia Alpha- Antitrypsin Deficiency Treatment Sales and Value (2013-2018)
  8.1.1 Southeast Asia Alpha- Antitrypsin Deficiency Treatment Sales Volume and Growth Rate (2013-2018)
  8.1.2 Southeast Asia Alpha- Antitrypsin Deficiency Treatment Revenue and Growth Rate (2013-2018)
  8.1.3 Southeast Asia Alpha- Antitrypsin Deficiency Treatment Sales Price Trend (2013-2018)
8.2 Southeast Asia Alpha- Antitrypsin Deficiency Treatment Sales Volume and Market Share by Type
8.3 Southeast Asia Alpha- Antitrypsin Deficiency Treatment Sales Volume and Market Share by Application

9 AUSTRALIA ALPHA- ANTITRYPSIN DEFICIENCY TREATMENT (VOLUME, VALUE AND SALES PRICE)

9.1 Australia Alpha- Antitrypsin Deficiency Treatment Sales and Value (2013-2018)
  9.1.1 Australia Alpha- Antitrypsin Deficiency Treatment Sales Volume and Growth Rate (2013-2018)
  9.1.2 Australia Alpha- Antitrypsin Deficiency Treatment Revenue and Growth Rate (2013-2018)
  9.1.3 Australia Alpha- Antitrypsin Deficiency Treatment Sales Price Trend (2013-2018)
9.2 Australia Alpha- Antitrypsin Deficiency Treatment Sales Volume and Market Share by Type
9.3 Australia Alpha- Antitrypsin Deficiency Treatment Sales Volume and Market Share by Application

10 ASIA-PACIFIC ALPHA- ANTITRYPSIN DEFICIENCY TREATMENT PLAYERS/SUPPLIERS PROFILES AND SALES DATA

10.1 Adverum Biotechnologies, Inc.
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Alpha- Antitrypsin Deficiency Treatment Product Category, Application and Specification
    10.1.2.1 Product A
    10.1.2.2 Product B
  10.1.3 Adverum Biotechnologies, Inc. Alpha- Antitrypsin Deficiency Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  10.1.4 Main Business/Business Overview
10.2 Alnylam Pharmaceuticals, Inc.
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Alpha- Antitrypsin Deficiency Treatment Product Category, Application and Specification
    10.2.2.1 Product A
    10.2.2.2 Product B
  10.2.3 Alnylam Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  10.2.4 Main Business/Business Overview
10.3 Applied Genetic Technologies Corporation
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Alpha- Antitrypsin Deficiency Treatment Product Category, Application and Specification
    10.3.2.1 Product A
    10.3.2.2 Product B
  10.3.3 Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  10.3.4 Main Business/Business Overview
10.4 Arrowhead Pharmaceuticals, Inc.
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Alpha- Antitrypsin Deficiency Treatment Product Category, Application and Specification
    10.4.2.1 Product A
    10.4.2.2 Product B
  10.4.3 Arrowhead Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  10.4.4 Main Business/Business Overview
10.5 Carolus Therapeutics, Inc.
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Alpha- Antitrypsin Deficiency Treatment Product Category, Application and Specification
    10.5.2.1 Product A
    10.5.2.2 Product B
  10.5.3 Carolus Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  10.5.4 Main Business/Business Overview
10.6 Cevec Pharmaceuticals GmbH
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Alpha- Antitrypsin Deficiency Treatment Product Category, Application and Specification
    10.6.2.1 Product A
    10.6.2.2 Product B
  10.6.3 Cevec Pharmaceuticals GmbH Alpha- Antitrypsin Deficiency Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  10.6.4 Main Business/Business Overview
10.7 Dicerna Pharmaceuticals, Inc.
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Alpha- Antitrypsin Deficiency Treatment Product Category, Application and Specification
    10.7.2.1 Product A
    10.7.2.2 Product B
  10.7.3 Dicerna Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  10.7.4 Main Business/Business Overview
10.8 Digna Biotech, S.L.
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Alpha- Antitrypsin Deficiency Treatment Product Category, Application and Specification
    10.8.2.1 Product A
    10.8.2.2 Product B
  10.8.3 Digna Biotech, S.L. Alpha- Antitrypsin Deficiency Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  10.8.4 Main Business/Business Overview
10.9 Editas Medicine, Inc.
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Alpha- Antitrypsin Deficiency Treatment Product Category, Application and Specification
    10.9.2.1 Product A
    10.9.2.2 Product B
  10.9.3 Editas Medicine, Inc. Alpha- Antitrypsin Deficiency Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  10.9.4 Main Business/Business Overview
10.10 Grifols, S.A.
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Alpha- Antitrypsin Deficiency Treatment Product Category, Application and Specification
    10.10.2.1 Product A
    10.10.2.2 Product B
  10.10.3 Grifols, S.A. Alpha- Antitrypsin Deficiency Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  10.10.4 Main Business/Business Overview
10.11 Inhibrx
10.12 Intellia Therapeutics, Inc.
10.13 International Stem Cell Corporation
10.14 Ionis Pharmaceuticals, Inc.
10.15 Kamada Ltd.
10.16 Polyphor Ltd.
10.17 ProMetic Life Sciences Inc.
10.18 rEVO Biologics, Inc.
10.19 Sangamo BioSciences, Inc.

11 ALPHA- ANTITRYPSIN DEFICIENCY TREATMENT MANUFACTURING COST ANALYSIS

11.1 Alpha- Antitrypsin Deficiency Treatment Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Alpha- Antitrypsin Deficiency Treatment

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Alpha- Antitrypsin Deficiency Treatment Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Alpha- Antitrypsin Deficiency Treatment Major Manufacturers in 2017
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 ASIA-PACIFIC ALPHA- ANTITRYPSIN DEFICIENCY TREATMENT MARKET FORECAST (2018-2025)

15.1 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Sales Volume, Revenue and Price Forecast (2018-2025)
  15.1.1 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Sales Volume and Growth Rate Forecast (2018-2025)
  15.1.2 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Revenue and Growth Rate Forecast (2018-2025)
  15.1.3 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Price and Trend Forecast (2018-2025)
15.2 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
  15.2.1 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Sales Volume and Growth Rate Forecast by Region (2018-2025)
  15.2.2 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Revenue and Growth Rate Forecast by Region (2018-2025)
  15.2.3 China Alpha- Antitrypsin Deficiency Treatment Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.4 Japan Alpha- Antitrypsin Deficiency Treatment Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.5 South Korea Alpha- Antitrypsin Deficiency Treatment Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.6 Taiwan Alpha- Antitrypsin Deficiency Treatment Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.7 India Alpha- Antitrypsin Deficiency Treatment Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.8 Southeast Asia Alpha- Antitrypsin Deficiency Treatment Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.9 Australia Alpha- Antitrypsin Deficiency Treatment Sales, Revenue and Growth Rate Forecast (2018-2025)
15.3 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Sales, Revenue and Price Forecast by Type (2018-2025)
  15.3.1 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Sales Forecast by Type (2018-2025)
  15.3.2 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Revenue Forecast by Type (2018-2025)
  15.3.3 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Price Forecast by Type (2018-2025)
15.4 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Sales Forecast by Application (2018-2025)

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology/Research Approach
  17.1.1 Research Programs/Design
  17.1.2 Market Size Estimation
  17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
  17.2.1 Secondary Sources
  17.2.2 Primary Sources
17.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.


List of Tables and Figures

Figure Product Picture of Alpha- Antitrypsin Deficiency Treatment
Figure Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Sales Volume (K Pcs) by Type (2013-2025)
Figure Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Type (Product Category) in 2017
Figure CT-2009 Product Picture
Figure POL-6014 Product Picture
Figure ARO-AAT Product Picture
Figure ALNAAT-02 Product Picture
Figure Others Product Picture
Figure Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs) by Application (2013-2025)
Figure Asia-Pacific Sales Market Share of Alpha- Antitrypsin Deficiency Treatment by Application in 2017
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Others Examples
Table Key Downstream Customer in Others
Figure Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Size (Million USD) by Region (2013-2025)
Figure China Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure South Korea Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure Taiwan Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure Australia Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Sales Volume (K Pcs) and Growth Rate (2013-2025)
Figure Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Major Players Product Sales Volume (K Pcs)(2013-2018)
Table Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs) of Key Players/Suppliers (2013-2018)
Table Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Sales Share by Players/Suppliers
Figure Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Major Players Product Revenue (Million USD) 2013-2018
Table Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Revenue Share by Players
Figure 2017 Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Revenue Share by Players
Table Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Sales and Market Share by Type (2013-2018)
Table Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Sales Share by Type (2013-2018)
Figure Sales Market Share of Alpha- Antitrypsin Deficiency Treatment by Type (2013-2018)
Figure Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Sales Growth Rate by Type (2013-2018)
Table Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) and Market Share by Type (2013-2018)
Table Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Alpha- Antitrypsin Deficiency Treatment by Type (2013-2018)
Figure Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Revenue Growth Rate by Type (2013-2018)
Table Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Sales Volume (K Pcs) and Market Share by Region (2013-2018)
Table Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Sales Share by Region (2013-2018)
Figure Sales Market Share of Alpha- Antitrypsin Deficiency Treatment by Region (2013-2018)
Figure Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Sales Market Share by Region in 2017
Table Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) and Market Share by Region (2013-2018)
Table Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Alpha- Antitrypsin Deficiency Treatment by Region (2013-2018)
Figure Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Revenue Market Share by Region in 2017
Table Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Sales Volume (K Pcs) and Market Share by Application (2013-2018)
Table Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Sales Share (%) by Application (2013-2018)
Figure Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Sales Market Share by Application (2013-2018)
Figure Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Sales Market Share by Application (2013-2018)
Figure China Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure China Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Alpha- Antitrypsin Deficiency Treatment Sales Price (USD/Pcs) Trend (2013-2018)
Table China Alpha- Antitrypsin Deficiency Treatment Sales Volume (K Pcs) by Type (2013-2018)
Table China Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Type (2013-2018)
Figure China Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Type in 2017
Table China Alpha- Antitrypsin Deficiency Treatment Sales Volume (K Pcs) by Applications (2013-2018)
Table China Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Application (2013-2018)
Figure China Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Application in 2017
Figure Japan Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Japan Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Alpha- Antitrypsin Deficiency Treatment Sales Price (USD/Pcs) Trend (2013-2018)
Table Japan Alpha- Antitrypsin Deficiency Treatment Sales Volume (K Pcs) by Type (2013-2018)
Table Japan Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Type (2013-2018)
Figure Japan Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Type in 2017
Table Japan Alpha- Antitrypsin Deficiency Treatment Sales Volume (K Pcs) by Applications (2013-2018)
Table Japan Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Application (2013-2018)
Figure Japan Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Application in 2017
Figure South Korea Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure South Korea Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate (2013-2018)
Figure South Korea Alpha- Antitrypsin Deficiency Treatment Sales Price (USD/Pcs) Trend (2013-2018)
Table South Korea Alpha- Antitrypsin Deficiency Treatment Sales Volume (K Pcs) by Type (2013-2018)
Table South Korea Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Type (2013-2018)
Figure South Korea Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Type in 2017
Table South Korea Alpha- Antitrypsin Deficiency Treatment Sales Volume (K Pcs) by Applications (2013-2018)
Table South Korea Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Application (2013-2018)
Figure South Korea Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Application in 2017
Figure Taiwan Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Taiwan Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate (2013-2018)
Figure Taiwan Alpha- Antitrypsin Deficiency Treatment Sales Price (USD/Pcs) Trend (2013-2018)
Table Taiwan Alpha- Antitrypsin Deficiency Treatment Sales Volume (K Pcs) by Type (2013-2018)
Table Taiwan Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Type (2013-2018)
Figure Taiwan Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Type in 2017
Table Taiwan Alpha- Antitrypsin Deficiency Treatment Sales Volume (K Pcs) by Applications (2013-2018)
Table Taiwan Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Application (2013-2018)
Figure Taiwan Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Application in 2017
Figure India Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure India Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Alpha- Antitrypsin Deficiency Treatment Sales Price (USD/Pcs) Trend (2013-2018)
Table India Alpha- Antitrypsin Deficiency Treatment Sales Volume (K Pcs) by Type (2013-2018)
Table India Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Type (2013-2018)
Figure India Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Type in 2017
Table India Alpha- Antitrypsin Deficiency Treatment Sales Volume (K Pcs) by Application (2013-2018)
Table India Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Application (2013-2018)
Figure India Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Application in 2017
Figure Southeast Asia Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Southeast Asia Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Alpha- Antitrypsin Deficiency Treatment Sales Price (USD/Pcs) Trend (2013-2018)
Table Southeast Asia Alpha- Antitrypsin Deficiency Treatment Sales Volume (K Pcs) by Type (2013-2018)
Table Southeast Asia Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Type in 2017
Table Southeast Asia Alpha- Antitrypsin Deficiency Treatment Sales Volume (K Pcs) by Applications (2013-2018)
Table Southeast Asia Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Application in 2017
Figure Australia Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Australia Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate (2013-2018)
Figure Australia Alpha- Antitrypsin Deficiency Treatment Sales Price (USD/Pcs) Trend (2013-2018)
Table Australia Alpha- Antitrypsin Deficiency Treatment Sales Volume (K Pcs) by Type (2013-2018)
Table Australia Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Type (2013-2018)
Figure Australia Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Type in 2017
Table Australia Alpha- Antitrypsin Deficiency Treatment Sales Volume (K Pcs) by Applications (2013-2018)
Table Australia Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Application (2013-2018)
Figure Australia Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share by Application in 2017
Table Adverum Biotechnologies, Inc. Alpha- Antitrypsin Deficiency Treatment Basic Information List
Table Adverum Biotechnologies, Inc. Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Adverum Biotechnologies, Inc. Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Adverum Biotechnologies, Inc. Alpha- Antitrypsin Deficiency Treatment Sales Market Share in Asia-Pacific (2013-2018)
Figure Adverum Biotechnologies, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue Market Share in Asia-Pacific (2013-2018)
Table Alnylam Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Basic Information List
Table Alnylam Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Alnylam Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Alnylam Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Sales Market Share in Asia-Pacific (2013-2018)
Figure Alnylam Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue Market Share in Asia-Pacific (2013-2018)
Table Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Basic Information List
Table Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Sales Market Share in Asia-Pacific (2013-2018)
Figure Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Revenue Market Share in Asia-Pacific (2013-2018)
Table Arrowhead Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Basic Information List
Table Arrowhead Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Arrowhead Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Arrowhead Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Sales Market Share in Asia-Pacific (2013-2018)
Figure Arrowhead Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue Market Share in Asia-Pacific (2013-2018)
Table Carolus Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Basic Information List
Table Carolus Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Carolus Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Carolus Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Sales Market Share in Asia-Pacific (2013-2018)
Figure Carolus Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue Market Share in Asia-Pacific (2013-2018)
Table Cevec Pharmaceuticals GmbH Alpha- Antitrypsin Deficiency Treatment Basic Information List
Table Cevec Pharmaceuticals GmbH Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Cevec Pharmaceuticals GmbH Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Cevec Pharmaceuticals GmbH Alpha- Antitrypsin Deficiency Treatment Sales Market Share in Asia-Pacific (2013-2018)
Figure Cevec Pharmaceuticals GmbH Alpha- Antitrypsin Deficiency Treatment Revenue Market Share in Asia-Pacific (2013-2018)
Table Dicerna Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Basic Information List
Table Dicerna Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Dicerna Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Dicerna Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Sales Market Share in Asia-Pacific (2013-2018)
Figure Dicerna Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue Market Share in Asia-Pacific (2013-2018)
Table Digna Biotech, S.L. Alpha- Antitrypsin Deficiency Treatment Basic Information List
Table Digna Biotech, S.L. Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Digna Biotech, S.L. Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Digna Biotech, S.L. Alpha- Antitrypsin Deficiency Treatment Sales Market Share in Asia-Pacific (2013-2018)
Figure Digna Biotech, S.L. Alpha- Antitrypsin Deficiency Treatment Revenue Market Share in Asia-Pacific (2013-2018)
Table Editas Medicine, Inc. Alpha- Antitrypsin Deficiency Treatment Basic Information List
Table Editas Medicine, Inc. Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Editas Medicine, Inc. Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Editas Medicine, Inc. Alpha- Antitrypsin Deficiency Treatment Sales Market Share in Asia-Pacific (2013-2018)
Figure Editas Medicine, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue Market Share in Asia-Pacific (2013-2018)
Table Grifols, S.A. Alpha- Antitrypsin Deficiency Treatment Basic Information List
Table Grifols, S.A. Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Grifols, S.A. Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs) and Growth Rate (2013-2018)
Figure Grifols, S.A. Alpha- Antitrypsin Deficiency Treatment Sales Market Share in Asia-Pacific (2013-2018)
Figure Grifols, S.A. Alpha- Antitrypsin Deficiency Treatment Revenue Market Share in Asia-Pacific (2013-2018)
Table Inhibrx Alpha- Antitrypsin Deficiency Treatment Basic Information List
Table Intellia Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Basic Information List
Table International Stem Cell Corporation Alpha- Antitrypsin Deficiency Treatment Basic Information List
Table Ionis Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Basic Information List
Table Kamada Ltd. Alpha- Antitrypsin Deficiency Treatment Basic Information List
Table Polyphor Ltd. Alpha- Antitrypsin Deficiency Treatment Basic Information List
Table ProMetic Life Sciences Inc. Alpha- Antitrypsin Deficiency Treatment Basic Information List
Table rEVO Biologics, Inc. Alpha- Antitrypsin Deficiency Treatment Basic Information List
Table Sangamo BioSciences, Inc. Alpha- Antitrypsin Deficiency Treatment Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Pcs) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Alpha- Antitrypsin Deficiency Treatment
Figure Manufacturing Process Analysis of Alpha- Antitrypsin Deficiency Treatment
Figure Alpha- Antitrypsin Deficiency Treatment Industrial Chain Analysis
Table Raw Materials Sources of Alpha- Antitrypsin Deficiency Treatment Major Manufacturers in 2017
Table Major Buyers of Alpha- Antitrypsin Deficiency Treatment
Table Distributors/Traders List
Figure Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Price (USD/Pcs) and Trend Forecast (2018-2025)
Table Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Sales Volume (K Pcs) Forecast by Region (2018-2025)
Figure Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share Forecast by Region (2018-2025)
Figure Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Sales Volume Market Share Forecast by Region in 2025
Table Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) Forecast by Region (2018-2025)
Figure Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Revenue Market Share Forecast by Region (2018-2025)
Figure Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Revenue Market Share Forecast by Region in 2025
Figure China Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs) and Growth Rate Forecast (2018-2025)
Figure China Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Japan Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure South Korea Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs) and Growth Rate Forecast (2018-2025)
Figure South Korea Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Taiwan Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Taiwan Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs) and Growth Rate Forecast (2018-2025)
Figure India Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Australia Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Australia Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs) Forecast by Type (2018-2025)
Figure Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Sales Market Share Forecast by Type (2018-2025)
Table Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Revenue (Million USD) Forecast by Type (2018-2025)
Figure Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Revenue Market Share Forecast by Type (2018-2025)
Table Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Price (USD/Pcs) Forecast by Type (2018-2025)
Table Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Sales (K Pcs) Forecast by Application (2018-2025)
Figure Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources